Reperfusion therapy is the indispensable treatment of acute myocardial infarction (AMI) and must be applied as soon as possible to attenuate the ischemic insult. However, reperfusion is responsible for additional myocardial damage likely involving opening of the mitochondrial permeability transition pore (mPTP). A great part of reperfusion injury occurs during the first minute of reperfusion. The prolonged opening of mPTP is considered one of the endpoints of the cascade to myocardial damage, causing loss of cardiomyocyte function and viability. Opening of mPTP and the consequent oxidative stress due to reactive oxygen and nitrogen species (ROS/RNS) are considered among the major mechanisms of mitochondrial and myocardial dysfunction. Kinases and mitochondrial components constitute an intricate network of signaling molecules and mitochondrial proteins, which interact in response to stressors. Cardioprotective pathways are activated by stimuli such as preconditioning and postconditioning (PostC), obtained with brief intermittent ischemia or with pharmacological agents, which drastically reduce the lethal ischemia/reperfusion injury. The protective pathways converging on mitochondria may preserve their function. Protection involves kinases, adenosine triphosphate-dependent potassium channels, ROS signaling, and the mPTP modulation. Some clinical studies using ischemic PostC during angioplasty support its protective effects, and an interesting alternative is pharmacological PostC. In fact, the mPTP desensitizer, cyclosporine A, has been shown to induce appreciable protections in AMI patients. Several factors and comorbidities that might interfere with cardioprotective signaling are considered. Hence, treatments adapted to the characteristics of the patient (i.e., phenotype oriented) might be feasible in the future. Antioxid. Redox Signal. 18, 556–599.
AbeteP, CacciatoreF, TestaG, Della-MorteD, GaliziaG, de SantisD, CalabreseC, CioppaA, FerraraN, RengoF. Ischemic preconditioning in the aging heart: from bench to bedside. Ageing Res Rev, 9:153–162. 2010.
2.
AbeteP, CalabreseC, FerraraN, CioppaA, PisanelliP, CacciatoreF, LongobardiG, NapoliC, RengoF. Exercise training restores ischemic preconditioning in the aging heart. J Am Coll Cardiol, 36:643–650. 2000.
3.
AbeteP, TestaG, FerraraN, De SantisD, CapaccioP, ViatiL, CalabreseC, CacciatoreF, LongobardiG, CondorelliM, NapoliC, RengoF. Cardioprotective effect of ischemic preconditioning is preserved in food-restricted senescent rats. Am J Physiol Heart Circ Physiol, 282:H1978–H1987. 2002.
4.
AndersonPG, AllardMF, ThomasGD, BishopSP, DigernessSB. Increased ischemic injury but decreased hypoxic injury in hypertrophied rat hearts. Circ Res, 67:948–959. 1990.
5.
ArgaudL, Gateau-RoeschO, AugeulL, Couture-LepetitE, LoufouatJ, GomezL, RobertD, OvizeM. Increased mitochondrial calcium coexists with decreased reperfusion injury in postconditioned (but not preconditioned) hearts. Am J Physiol Heart Circ Physiol, 294:H386–H391. 2008.
BainesCP, KaiserRA, PurcellNH, BlairNS, OsinskaH, HambletonMA, BrunskillEW, SayenMR, GottliebRA, DornGW, RobbinsJ, MolkentinJD. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature, 434:658–662. 2005.
8.
BainesCP, KaiserRA, SheikoT, CraigenWJ, MolkentinJD. Voltage dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat Cell Biol, 9:550–555. 2007.
9.
BainesCP, ZhangJ, WangG-W, ZhengY-T, XiuJX, CardwellEM, BolliR, PingP. Mitochondrial PKCɛ and MAPK form signaling modules in the murine heart. Circ Res, 90:390–397. 2002.
10.
BainesCP. The mitochondrial permeability transition pore and ischemia/reperfusion injury. Basic Res Cardiol, 104:181–188. 2009.
11.
BargerPM, KellyDP. PPAR signaling in the control of cardiac energy metabolism. Trends Cardiovasc Med, 10:238–245. 2000.
12.
BassoE, PetronilliV, ForteMA, BernardiP. Phosphate is essential for inhibition of the mitochondrial permeability transition pore by cyclosporin A and by cyclophilin D ablation. J Biol Chem, 283:26307–26311. 2008.
13.
BatistG, MersereauW, MalashenkoBA, ChiuRC. Response to ischemia-reperfusion injury in hypertrophic heart. Role of free-radical metabolic pathways. Circulation, 80:III10–13. 1989.
BaurJA, PearsonKJ, PriceNL, JamiesonHA, LerinC, KalraA, PrabhuVV, AllardJS, Lopez-LluchG, LewisK, PistellPJ, PoosalaS, BeckerKG, BossO, GwinnD, WangM, RamaswamyS, FishbeinKW, SpencerRG, LakattaEG, Le CouteurD, ShawRJ, NavasP, PuigserverP, IngramDK, de CaboR, SinclairDA. Resveratrol improves health and survival of mice on a high-calorie diet. Nature, 444:337–342. 2006.
16.
BeauloyeC, BertrandL, HormanS, HueL. AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure. Cardiovasc Res, 90:224–233. 2011.
17.
BeckerLB, vanden HoekTL, ShaoZ-H, LiC-Q, SchumackerPT. Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am J Physiol Heart Circ Physiol, 277:H2240–H2246. 1999.
18.
BeckmanJS, KoppenolWH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol, 271:C1424–C1437. 1996.
19.
BeckmanJS, BeckmanTW, ChenJ, MarshallPA, FreemanBA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A, 87:1620–1624. 1990.
20.
BeltranB, MathurA, DuchenMR, ErusalimskyJD, MoncadaS. The effect of nitric oxide on cell respiration: a key to understanding its role in cell survival or death. Proc Natl Acad Sci U S A, 97:14602–14607. 2000.
21.
BernardiP, KrauskopfA, BassoE, PetronilliV, Blalchy-DysonE, Di LisaF, ForteMA. The mitochondrial permeability transition from in vitro artifact to disease target. FEBS J, 273:2077–2099. 2006.
22.
BinbrekAS, RaoNS, Al KhajaN, AssaqqafJ, SobelBE. Erythropoietin to augment myocardial salvage induced by coronary thrombolysis in patients with ST segment elevation acute myocardial infarction. Am J Cardiol, 104:1035–1040. 2009.
BodyakN, RigorDL, ChenYS, HanY, BispingE, PuWT, KangPM. Uncoupling protein 2 modulates cell viability in adult rat cardiomyocytes. Am J Physiol Heart Circ Physiol, 293:H829–H835. 2007.
25.
BoenglerK, BuechertA, HeinenY, RoeskesC, Hilfiker-KleinerD, HeuschG, SchulzR. Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice. Circ Res, 102:131–135. 2008.
26.
BoenglerK, DodoniG, Ruiz-MeanaM, CabestreroA, Rodriguez-SinovasA, Garcia-DoradoD, GresP, Di LisaF, HeuschG, SchulzR. Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning. Cardiovasc Res, 67:234–244. 2005.
BoenglerK, Hilfiker-KleinerD, DrexlerH, HeuschG, SchulzR. The myocardial JAK/STAT pathway: from protection to failure. Pharmacol Ther, 120:172–185. 2008.
29.
BoenglerK, Hilfiker-KleinerD, HeuschG, SchulzR. Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion. Basic Res Cardiol, 105:771–785. 2010.
30.
BoenglerK, KonietzkaI, BuechertA, HeinenY, Garcia-DoradoD, HeuschG, SchulzR. Loss of ischemic preconditioning's cardioprotection in aged mouse hearts is associated with reduced gap junctional and mitochondrial levels of connexin 43. Am J Physiol Heart Circ Physiol, 292:H1764–H1769. 2007.
31.
BoenglerK, SchulzR, HeuschG. Loss of cardioprotection with ageing. Cardiovasc Res, 83:247–261. 2009.
32.
BoenglerK, StahlhofenS, van de SandA, GresP, Ruiz-MeanaM, Garcia-DoradoD, HeuschG, SchulzR. Presence of connexin 43 in subsarcolemmal, but not in interfibrillar cardiomyocyte mitochondria. Basic Res Cardiol, 104:141–147. 2009.
33.
BolliR, BeckerL, GrossG, MentzerRJr., BalshawD, LathropDA. Myocardial protection at a crossroads: the need for translation into clinical therapy. Circ Res, 95:125–134. 2004.
34.
BolliR, DawnB, XuanY-T. Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury. Trends Cardiovasc Med, 13:72–79. 2003.
35.
BolliR, LiQH, TangXL, GuoY, XuanYT, RokoshG, DawnB. The late phase of preconditioning and its natural clinical application—gene therapy. Heart Fail Rev, 12:189–199. 2007.
36.
BolliR, SteinAB, GuoY, WangOL, RokoshG, DawnB, MolkentinJD, SanganalmathSK, ZhuY, XuanYT. A murine model of inducible, cardiac-specific deletion of STAT3: its use to determine the role of STAT3 in the upregulation of cardioprotective proteins by ischemic preconditioning. J Mol Cell Cardiol, 50:589–597. 2011.
37.
BolliR. Preconditioning: a paradigm shift in the biology of myocardial ischemia. Am J Physiol Heart Circ Physiol, 292:H19–H27. 2007.
38.
BoudinaS, SenaS, TheobaldH, ShengXM, WrightJJ, HuXX, AzizS, JohnsonJI, BuggerH, ZahaVG, AbelED. Mitochondrial energetics in the heart in obesity-related diabetes—direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes, 56:2457–2466. 2007.
39.
BouhidelO, PonsS, SouktaniR, ZiniR, BerdeauxA, GhalehB. Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice. Am J Physiol Heart Circ Physiol, 295:H1580–H1586. 2008.
40.
BrandMD, EstevesTC. Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3. Cell Metab, 2:85–93. 2005.
BudasGR, ChurchillEN, DisatnikM-H, SunL, Mochly-RosenD. Mitochondrial import of PKCɛ is mediated by HSP90: a role in cardioprotection from ischaemia and reperfusion injury. Cardiovasc Res, 88:83–92. 2010.
43.
BuggerH, AbelED. Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome. Clin Sci (Lond), 114:195–210. 2008.
44.
BullardAJ, GovewallaP, YellonDM. Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo. Basic Res Cardiol, 100:397–403. 2005.
45.
BurnsPG, KrunkenkampIB, CalderoneCA, KirvaitisRJ, GaudetteGR, LevitskyS. Is the preconditioning response conserved in senescent myocardium?Ann Thorac Surg, 61:925–929. 1996.
46.
BurwellLS, NadtochiySM, BrookesPS. Cardioprotection by metabolic shut-down and gradual wake-up. J Mol Cell Cardiol, 46:804–810. 2009.
47.
BurwellLS, NadtochiySM, TompkinsAJ, YoungS, BrookesPS. Direct evidence for S-nitrosylation of mitochondrial complex I. Biochem J, 394:627–634. 2006.
ChenZP, MitchelhillKI, MichellBJ, StapletonD, Rodriguez-CrespoI, WittersLA, PowerDA, Ortiz de MontellanoPR, KempBE. AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett, 443:285–289. 1999.
54.
ChouCJ, ChaMC, JungDW, BoozerCN, HashimSA, Pi-SunyerFX. High-fat diet feeding elevates skeletal muscle uncoupling protein 3 levels but not its activity in rats. Obes Res, 9:313–319. 2001.
55.
ChurchillEN, Mochly-RosenD. The roles of PKCdelta and epsilon isoenzymes in the regulation of myocardial ischaemia/reperfusion injury. Biochem Soc Trans, 35:1040–1042. 2007.
56.
ChurchillEN, DisatnikMH, Mochly-RosenD. Time-dependent and ethanol induced cardiac protection from ischemia mediated by mitochondrial translocation of variant PKCɛ and activation of aldehyde dehydrogenase 2. J Mol Cell Cardiol, 46:278–284. 2009.
57.
ChurchillEN, FerreiraJC, BrumPC, SzwedaLI, Mochly-RosenD. Ischaemic preconditioning improves proteasomal activity and increases the degradation of deltaPKC during reperfusion. Cardiovasc Res, 85:385–394. 2010.
58.
ChurchillEN, MurrielCL, ChenCH, Mochly-RosenD, SzwedaLI. Reperfusion-induced translocation of deltaPKC to cardiac mitochondria prevents pyruvate dehydrogenase reactivation. Circ Res, 97:78–85. 2005.
59.
ClarkeSJ, KhaliulinI, DasM, ParkerJE, HeesomKJ, HalestrapAP. Inhibition of mitochondrial permeability transition pore opening by ischemic preconditioning is probably mediated by reduction of oxidative stress rather than mitochondrial protein phosphorylation. Circ Res, 102:1082–1090. 2008.
60.
CohenMV, DowneyJM. Adenosine: trigger and mediator of cardioprotection. Basic Res Cardiol, 103:203–215. 2008.
61.
CohenMV, DowneyJM. Ischemic postconditioning: from receptor to end-effector. Antioxid Redox Signal, 14:821–831. 2011.
62.
CohenMV, YangX-M, DowneyJM. Acidosis, oxygen, and interference with mitochondrial permeability transition pore formation in the early minutes of reperfusion are critical to postconditioning's success. Basic Res Cardiol, 103:464–471. 2008.
63.
CohenMV, YangXM, DowneyJM. Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategies. Cardiovasc Res, 70:231–229. 2006.
64.
CohenMV, YangX-M, DowneyJM. The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation, 115:1895–1903. 2007.
65.
CorreaF, GarcíaN, RoblesC, Martínez-AbundisE, ZazuetaC. Relationship between oxidative stress and mitochondrial function in the post-conditioned heart. J Bioenerg Biomembr, 40:599–606. 2008.
66.
CostaAD, GarlidKD. Intramitochondrial signaling—interactions among mitoKATP, PKCɛ, ROS, and MPT. Am J Physiol Heart Circ Physiol, 295:H874–H882. 2008.
67.
CostaAD, GarlidKD. MitoKATP activity in healthy and ischemic hearts. J Bioenerg Biomembr, 41:123–126. 2009.
68.
CostaAD, PierreSV, CohenMV, DowneyJM, GarlidKD. cGMP signalling in pre- and post-conditioning: the role of mitochondria. Cardiovasc Res, 77:344–352. 2008.
69.
CrisafulliA, MelisF, ToccoF, SantoboniUM, LaiC, AngioyG, LorraiL, PittauG, ConcuA, PagliaroP. Exercise-induced and nitroglycerin-induced myocardial preconditioning improves hemodynamics in patients with angina. Am J Physiol Heart Circ Physiol, 287:H235–H242. 2004.
70.
CromptonM. The mitochondrial permeability transition pore and its role in cell death. Biochem J, 341:233–249. 1999.
71.
CsontT, SzilvássyZ, FülöpF, NedeianuS, PáliT, TosakiA, DuxL, FerdinandyP. Direct myocardial anti-ischaemic effect of GTN in both nitrate-tolerant and nontolerant rats: a cyclic GMP-independent activation of KATP. Br J Pharmacol, 128:1427–1434. 1999.
72.
DaiberA. Redox signaling (cross-talk) from and to mitochondria involves mitochondrial pores and reactive oxygen species. Biochim Biophys Acta, 1797:897–906. 2010.
73.
DasA, XiL, KukrejaRC. Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling. J Biol Chem, 280:12944–12955. 2005.
74.
DasM, ParkerJE, HalestrapAP. Matrix volume measurements challenge the existence of diazoxide/glibencamide-sensitive KATP channels in rat mitochondria. J Physiol, 547:893–902. 2003.
de BritoOM, ScorranoL. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature, 456:605–610. 2008.
77.
DepreC, ParkJY, ShenYT, ZhaoX, QiuH, YanL, TianB, VatnerSF, VatnerDE. Molecular mechanisms mediating preconditioning following chronic ischemia differ from those in classical second window. Am J Physiol Heart Circ Physiol, 299:H752–H762. 2010.
78.
Di LisaF, BernardiP. A CaPful of mechanisms regulating the mitochondrial permeability transition. J Mol Cell Cardiol, 46:775–778. 2009.
79.
Di LisaF, ZieglerM. Pathophysiological relevance of mitochondria in NAD+ metabolism. FEBS Lett, 492:4–8. 2001.
80.
Di LisaF, BlankPS, ColonnaR, GambassiG, SilvermanHS, SternMD, HansfordRG. Mitochondrial membrane potential in single living adult rat cardiac myocytes exposed to anoxia or metabolic inhibition. J Physiol, 486:1–13. 1995.
81.
Di LisaF, CantonM, CarpiA, KaludercicN, MenabòR, MenazzaS, SemenzatoM. Mitochondrial injury and protection in ischemic pre- and post-conditioning. Antioxid Redox Signal, 14:881–891. 2011.
82.
Di LisaF, KaludercicN, CarpiA, MenabòR, GiorgioM. Mitochondrial pathways for ROS formation and myocardial injury: the relevance of p66(Shc) and monoamine oxidase. Basic Res Cardiol, 104:131–139. 2009.
83.
Di LisaF, MenabòR, CantonM, BarileM, BernardiP. Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J Biol Chem, 276:2571–2575. 2001.
84.
DimmerKS, ScorranoL. (De)constructing mitochondria: what for?Physiology, 21:233–241. 2006.
85.
DongY, UndyalaVV, GottliebRA, MentzerRMJr., PrzyklenkK. Autophagy: definition, molecular machinery and potential role in myocardial ischemia-reperfusion injury. J Cardiovasc Pharm Ther, 15:220–230. 2010.
86.
DongY, ZhangM, LiangB, XieZ, ZhaoZ, AsfaS, ChoiHC, ZouMH. Reduction of AMP-activated protein kinase α2 increases endoplasmic reticulum stress and atherosclerosis in vivo. Circulation, 121:792–803. 2010.
87.
Dos SantosP, LaclauMN, BoudinaS, GarlidKD. Alterations of the bioenergetics systems of the cell in acute and chronic myocardial ischemia. Mol Cell Biochem, 256–257:157–166. 2004.
88.
DosenkoVE, NagibinVS, TumanovskayaLV, MoibenkoAA, VaageJ. Postconditioning prevents apoptotic necrotic and autophagic cardiomyocyte cell death in culture. Fiziol Zh, 51:12–17. 2005.
89.
DostT, CohenMV, DowneyJM. Redox signaling triggers protection during the reperfusion rather than the ischemic phase of preconditioning. Basic Res Cardiol, 103:378–384. 2008.
90.
DowneyJM, CohenMV. We think we see a pattern emerging here. Circulation, 111:120–121. 2005.
91.
DrögeW. Free radicals in the physiological control of cell function. Physiol Rev, 82:47–95. 2002.
92.
EbrahimZ, YellonDM, BaxterGF. Attenuated cardioprotective response to bradykinin, but not classical preconditioning, in DOCA-salt hypertensive left ventricular hypertrophy. Pharmacol Res, 55:42–48. 2007.
93.
EbrahimZ, YellonDM, BaxterGF. Ischemic preconditioning is lost in aging hypertensive rat heart: independent effects of aging and longstanding hypertension. Exp Gerontol, 42:807–814. 2007.
94.
EchtayKS, EstevesTC, PakayJL, JekabsonsMB, LambertAJ, Portero-OtinM, PamplonaR, Vidal-PuigAJ, WangS, RoebuckSJ, BrandMD. A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. EMBO J, 22:4103–4110. 2003.
95.
EchtayKS, PakayJL, EstevesTC, BrandMD. Hydroxynonenal and uncoupling proteins: a model for protection against oxidative damage. Biofactors, 24:119–130. 2005.
EckelRH, GrundySM, ZimmetPZ. The metabolic syndrome. Lancet, 365:1415–1428. 2005.
98.
EliseevRA, MaleckiJ, LesterT, ZhangY, HumphreyJ, GunterTE. Cyclophilin D interacts with Bcl2 and exerts an anti-apoptotic effect. J Biol Chem, 284:9692–9699. 2009.
99.
EmerlingBM, WeinbergF, SnyderC, BurgessZ, MutluGM, ViolletB, BudingerGR, ChandelNS. Hypoxic activation of AMPK is dependent on mitochondrial ROS but independent of an increase in AMP/ATP ratio. Free Radic Biol Med, 46:1386–1391. 2009.
100.
EndoT, YamanoK. Multiple pathways for mitochondrial protein traffic. Biol Chem, 390:723–730. 2009.
101.
EsterbauerH, SchaurRJ, ZollnerH. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biol Med, 11:81–128. 1991.
102.
FacundoHT, de PaulaJG, KowaltowskiAJ. Mitochondrial ATP-sensitive K+ channels are redox-sensitive pathways that control reactive oxygen species production. Free Radic Biol Med, 42:1039–1048. 2007.
103.
FantinelliJC, MoscaSM. Comparative effects of ischemic pre and postconditioning on ischemia-reperfusion injury in spontaneously hypertensive rats (SHR)Mol Cell Biochem, 296:45–51. 2007.
104.
FerdinandyP, SchulzR, BaxterGF. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev, 59:418–458. 2007.
FinocchiettoPV, FrancoMC, HolodS, GonzalezAS, ConversoDP, Antico ArciuchVG, SerraMP, PoderosoJJ, CarrerasMC. Mitochondrial nitric oxide synthase: a masterpiece of metabolic adaptation, cell growth, transformation, and death. Exp Biol Med (Maywood), 234:1020–1028. 2009.
107.
FischerP, Hilfiker-KleinerD. Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis. Basic Res Cardiol, 102:279–297. 2007.
108.
FonsecaVA. The metabolic syndrome, hyperlipidemia, and insulin resistance. Clin Cornerstone, 7:61–72. 2005.
109.
ForbesRA, SteenbergenC, MurphyE. Diazoxide induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ Res, 88:802–809. 2001.
110.
FornazariM, de PaulaJG, CastilhoRF, KowaltowskiAJ. Redox properties of the adenoside triphosphate-sensitive K+ channel in brain mitochondria. J Neurosci Res, 86:1548–1556. 2008.
111.
FreixaX, BelleraN, Ortiz-PérezJT, JiménezM, ParéC, BoschX, De CaraltTM, BetriuA, MasottiM. Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention. Eur Heart J, 33:103–312. 2012.
112.
FujitaM, AsanumaH, HirataA, WakenoM, TakahamaH, SasakiH, KimJ, TakashimaS, TsukamotoO, MinaminoT, ShinozakiY, TomoikeH, HoriM, KitakazeM. Prolonged transient acidosis during early reperfusion contributes to the cardioprotective effects of postconditioning. Am J Physiol Heart Circ Physiol, 292:H2004–H2008. 2007.
113.
GarlidKD, CostaAD, QuinlanCL, PierreSV, Dos SantosP. Cardioprotective signaling to mitochondria. J Mol Cell Cardiol, 46:858–866. 2009.
114.
GiorgioM, MigliaccioE, OrsiniF, PaolucciD, MoroniM, ContursiC, PellicciaG, LuziL, MinucciS, MarcaccioM, PintonP, RizzutoR, BernardiP, PaolucciF, PelicciPG. Electron transfer between cytochrome c and p66(Shc) generates reactive oxygen species that trigger mitochondrial apoptosis. Cell, 122:221–233. 2005.
115.
GolsteinP, KroemerG. A multiplicity of cell death pathways. Symposium on apoptotic and non-apoptotic cell death pathways. EMBO Rep, 8:829–833. 2007.
116.
GolsteinP, KroemerG. Cell death by necrosis: towards a molecular definition. Trends Biochem Sci, 32:7–43. 2007.
117.
GomezL, PaillardM, ThibaultH, DerumeauxG, OvizeM. Inhibition of GSK3β by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation, 117:2761–2768. 2008.
118.
GottliebRA, GustafssonAB. Mitochondrial turnover in the heart. Biochim Biophys Acta, 1813:1295–1301. 2011.
119.
GreenDR, KroemerG. The pathophysiology of mitochondrial cell death. Science, 305:626–629. 2004.
120.
GreenK, BrandMD, MurphyMP. Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes, 53:S110–S118. 2004.
121.
GriffithsEJ, HalestrapAP. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J, 307:93–98. 1995.
122.
GriffithsEJ, HalestrapAP. Protection by Cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts. J Mol Cell Cardiol, 25:1461–1469. 1993.
123.
GrossER, HsuAK, GrossGJ. Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3βDiabetes, 56:127–136. 2007.
124.
GroverGJ, AtwalKS, SlephPG, WangFL, MonshizadeganH, MonticelloT, GreenDW. Excessive ATP hydrolysis in ischemic myocardium by mitochondrial F1F0-ATPase: effect of selective pharmacological inhibition of mitochondrial ATPase hydrolase activity. Am J Physiol Heart Circ Physiol, 287:H1747–H1755. 2004.
125.
GuthBD, SchulzR, HeuschG. Time course and mechanisms of contractile dysfunction during acute myocardial ischemia. Circulation, 87:IV35–42. 1993.
126.
HagenT, Vidal-PuigA. Mitochondrial uncoupling proteins in human physiology and disease. Minerva Med, 93:41–57. 2002.
127.
HalestrapAP, PasdoisP. The role of the mitochondrial permeability transition pore in heart disease. Biochim Biophys Acta, 1787:1402–1415. 2009.
128.
HalestrapAP, ClarkeSJ, JavadovSA. Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc Res, 61:372–385. 2004.
129.
HanleyPJ, MickelM, LöfflerM, BrandtU, DautJ. K(ATP) channel-independent targets of diazoxide and 5-hydroxydecanoate in the heart. J Physiol, 542:735–741. 2002.
HardieDG. AMP-activated protein kinase as a drug target. Annu Rev Pharmacol Toxicol, 47:185–210. 2007.
132.
HausenloyDJ, YellonDM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res, 61:448–460. 2004.
133.
HausenloyDJ, YellonDM. Preconditioning and postconditioning: united at reperfusion. Pharmacol Ther, 116:173–191. 2007.
HausenloyDJ, DuchenMR, YellonDM. Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovasc Res, 60:617–625. 2003.
136.
HausenloyDJ, LecourS, YellonDM. RISK and SAFE pro-survival signaling pathways in ischemic postconditioning: two sides of the same coin. Antioxid Redox Signal, 14:893–907. 2011.
137.
HausenloyDJ, LimSY, OngSG, DavidsonSM, YellonDM. Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning. Cardiovasc Res, 88:67–74. 2010.
138.
HausenloyDJ, OngSB, YellonDM. The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Res Cardiol, 104:189–202. 2009.
139.
HausenloyDJ, WynneAM, YellonDM. Ischemic preconditioning targets the reperfusion phase. Basic Res Cardiol, 102:445–452. 2007.
HausenloyDJ. Signalling pathways in ischaemic postconditioning. Thromb Haemost, 101:626–634. 2009.
142.
HeinzelFR, LuoY, LiX, BoenglerK, BuechertA, García-DoradoD, Di LisaF, SchulzR, HeuschG. Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice. Circ Res, 97:583–586. 2005.
143.
HeuschG, SchulzR. Preservation of peripheral vasodilation as a surrogate of cardioprotection? The mechanistic role of ATP-dependent potassium channels and the mitochondrial permeability transition pore. Eur Heart J, 32:1184–1186. 2011.
144.
HeuschG, BoenglerK, SchulzR. Cardioprotection: nitric oxide, protein kinases, and mitochondria. Circulation, 118:1915–1919. 2008.
145.
HeuschG, BoenglerK, SchulzR. Inhibition of mitochondrial permeability transition pore opening: the holy grail of cardioprotection. Basic Res Cardiol, 105:151–154. 2010.
146.
HeuschG, BüchertA, FeldhausS, SchulzR. No loss of cardioprotection by postconditioning in connexin 43-deficient mice. Basic Res Cardiol, 101:354–356. 2006.
147.
HeuschG, KleinbongardP, SkyschallyA, LevkauB, SchulzR, ErbelR. The coronary circulation in cardioprotection: more than just one confounder. Cardiovasc Res, 2011[Epub ahead of print]DOI:10.1093/cvr/cvr271
148.
HeuschG, MusiolikJ, KottenbergE, PetersJ, JakobH, ThielmannM. STAT-5 activation and cardioprotection by remote ischemic preconditioning in humans: short communication. Circ Res, 110:111–115. 2012.
149.
HeuschG, SkyschallyA, GresP, van CasterP, SchilawaD, SchulzR. Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine—protection beyond heart rate reduction. Eur Heart J, 29:2265–2275. 2008.
150.
HeuschG. Nitroglycerin and delayed preconditioning in humans: yet another new mechanism for an old drug?Circulation, 103:2876–2878. 2001.
151.
HeuschG. No risk, no…cardioprotection? A critical perspective. Cardiovasc Res, 84:173–175. 2009.
152.
HeuschG. Obesity—a risk factor or a RISK factor for myocardial infarction?Br J Pharmacol, 149:1–3. 2006.
153.
HeuschG. Postconditioning. Old wine in a new bottle?J Am Coll Cardiol, 44:1111–1112. 2004.
154.
HeuschG. Reduction of infarct size by ischaemic post-conditioning in humans: fact or fiction?Eur Heart J, 33:13–15. 2012.
155.
Hilfiker-KleinerD, HilfikerA, FuchsM, KaminskiK, SchaeferA, SchiefferB, HillmerA, SchmiedlA, DingZ, PodewskiE, PodewskiE, PoliV, SchneiderMD, SchulzR, ParkJK, WollertKC, DrexlerH. Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ Res, 95:187–195. 2004.
156.
Hilfiker-KleinerD. Survival pathways in hypertrophy and heart failure: the gp130-STAT-3 axis. Basic Res Cardiol, 102:279–297. 2007.
157.
HoerterJ, Gonzalez-BarrosoMD, CouplanE, MateoP, GellyC, Cassard-DoulcierAM, DiolezP, BouillaudF. Mitochondrial uncoupling protein 1expressed in the heart of transgenic mice protects against ischemic-reperfusion damage. Circulation, 110:528–533. 2004.
158.
HoshiM, TakashimaA, NoguchiK, MurayamaM, SatoM, KondoS, SaitohY, IshiguroK, HoshinoT, ImahoriK. Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3beta in brain. Proc Natl Acad Sci U S A, 93:2719–2723. 1996.
HuQ, SuzukiG, YoungRF, PageBJ, FallavollitaJA, CantyJMJr. Reductions in mitochondrial O(2) consumption and preservation of high-energy phosphate levels after simulated ischemia in chronic hibernating myocardium. Am J Physiol Heart Circ Physiol, 297:H223–H232. 2009.
161.
HuangC, AndresAM, RatliffEP, HernandezG, LeeP, GottliebRA. Preconditioning involves selective mitophagy mediated by Parkin and p62/SQSTM1. PLoS One, 6:e20975. 2011.
162.
HuangC, LiuW, PerryCN, YitzhakiS, LeeY, YuanH, TsukadaYT, Hamacher-BradyA, MentzerRMJr., GottliebRA. Autophagy and protein kinase C are required for cardioprotection by sulfaphenazole. Am J Physiol Heart Circ Physiol, 298:H570–H579. 2010.
163.
HuangC, YitzhakiS, PerryCN, LiuW, GiriczZ, MentzerRMJr., GottliebRA. Autophagy induced by ischemic preconditioning is essential for cardioprotection. J Cardiovasc Transl Res, 3:365–373. 2010.
164.
HuhnR, HeinenA, HollmannMW, SchlackW, PreckelB, WeberNC. Cyclosporine A administered during reperfusion fails to restore cardioprotection in prediabetic Zucker obese rats in vivo. Nutr Metab Cardiovasc Dis, 20:706–712. 2010.
165.
HuhnR, HeinenA, WeberNC, HollmannMW, SchlackW, PreckelB. Hyperglycaemia blocks sevoflurane-induced postconditioning in the rat heart in vivo: cardioprotection can be restored by blocking the mitochondrial permeability transition pore. Br J Anaesth, 100:465–471. 2008.
166.
HuisamenB. Protein kinase B in the diabetic heart. Mol Cell Biochem, 249:31–38. 2003.
167.
HunterDR, HaworthRA, SouthardJH. Relationship between configuration, function, and permeability in calcium-treated mitochondria. J Biol Chem, 251:5069–5077. 1976.
168.
HunterJC, KorzickDH. Age- and sex-dependent alterations in protein kinase C (PKC) and extracellular regulated kinase 1/2 (ERK1/2) in rat myocardium. Mech Ageing Dev, 126:535–550. 2005.
169.
HusainyMA, DickensonJM, GaliñanesM. The MPTP status during early reoxygenation is critical for cardioprotection. J Surg Res, 174:62–72. 2012.
170.
HüserJ, BlatterLA. Fluctuations in mitochondrial membrane potential caused by repetitive gating of the permeability transition pore. Biochem J, 343:311–317. 1999.
171.
IchasF, MazatJP. From calcium signaling to cell death: two conformations for the mitochondrial permeability transition pore. Switching from low- to high-conductance state. Biochim Biophys Acta, 1366:33–50. 1998.
172.
IchasF, JouavilleLS, MazatJP. Mitochondria are excitable organelles capable of generating and conveying electrical and calcium signals. Cell, 89:1145–1153. 1997.
173.
IliodromitisEK, AndreadouI, ProkovasE, ZogaA, FarmakisD, FotopoulouT, IoannidisK, ParaskevaidisIA, KremastinosDT. Simvastatin in contrast to postconditioning reduces infarct size in hyperlipidemic rabbits: possible role of oxidative/nitrosative stress attenuation. Basic Res Cardiol, 105:193–203. 2010.
174.
IliodromitisEK, DowneyJM, HeuschG, KremastinosDT. What is the optimal postconditioning algorithm?J Cardiovasc Pharmacol Ther, 14:269–273. 2009.
175.
InserteJ, Ruiz-MeanaM, Rodriguez-SinovasA, BarbaI, Garcia-DoradoD. Contribution of delayed intracellular pH recovery to ischemic postconditioning protection. Antioxid Redox Signal, 14:923–939. 2011.
176.
IrrcherI, LjubicicV, HoodDA. Interactions between ROS and AMP kinase activity in the regulation of PGC1α transcription in skeletal muscle cells. Am J Physiol Cell Physiol, 296:C116–C123. 2009.
177.
IrrcherI, LjubicicV, KirwanAF, HoodDA. AMP-activated protein kinase-regulated activation of the PGC1α promoter in skeletal muscle cells. PLoS One, 3:e3614. 2008.
178.
IshiiH, IchimiyaS, KanashiroM, AmanoT, ImaiK, MuroharaT, MatsubaraT. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction. Circulation, 112:1284–1288. 2005.
JacobsonJ, DuchenMR. Mitochondrial oxidative stress and cell death in astrocytes—requirement for stored Ca2+ and sustained opening of the permeability transition pore. J Cell Sci, 115:1175–1188. 2002.
181.
JacobyJJ, KalinowskiA, LiuMG, ZhangSS, GaoQ, ChaiGX, JiL, IwamotoY, LiE, SchneiderM, RussellKS, FuXY. Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age. Proc Natl Acad Sci U S A, 100:12929–12934. 2003.
182.
JalowyA, SchulzR, PostH, DörgeH, WeidenbachR, HeuschG. The angiotensin II AT1-receptor antagonist candesartan reduces infarct size in pigs. FASEB J, 12:A1114. 1998.
183.
JaswalJS, LundCR, KeungW, BekerDL, RebeykaIM, LopaschukGD. Isoproterenol stimulates 5′-AMP-activated protein kinase and fatty acid oxidation in neonatal hearts. Am J Physiol Heart Circ Physiol, 299:H1135–H1145. 2010.
184.
JavadovSA, ClarkeS, DasM, GriffithsEJ, LimKH, HalestrapAP. Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. J Physiol, 549:513–524. 2003.
JuhaszovaM, ZorovDB, YanivY, NussHB, WangS, SollottSJ. Role of glycogen synthase kinase-3β in cardioprotection. Circ Res, 104:1240–1252. 2009.
187.
KageyamaH, SugaA, KashibaM, OkaJ, OsakaT, KashiwaT, HiranoT, NemotoK, NambaY, RicquierD, GiacobinoJP, InoueS. Increased uncoupling protein-2 and -3 gene expressions in skeletal muscle of STZ-induced diabetic rats. FEBS Lett, 440:450–453. 1998.
188.
KanaiAJ, PearceLL, ClemensPR, BirderLA, VanBibberMM, ChoiSY, de GroatWC, PetersonJ. Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection. Proc Natl Acad Sci U S A, 98:14126–14131. 2001.
189.
KellyDE, HeJ, MenshikovaEV, RitovVB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes, 51:2944–2950. 2002.
190.
KerstenJR, TollerWG, GrossER, PagelPS, WarltierDC. Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality. Am J Physiol Heart Circ Physiol, 278:H1218–H1224. 2000.
191.
KevinLG, CamaraAK, RiessML, NovalijaE, StoweDF. Ischemic preconditioning alters real-time measure of O2 radicals in intact hearts with ischemia and reperfusion. Am J Physiol Heart Circ Physiol, 284:H566–H574. 2003.
192.
KinH, WangNP, MykytenkoJ, ReevesJ, DeneveJ, JiangR, ZattaAJ, GuytonRA, Vinten-JohansenJ, ZhaoZQ. Inhibition of myocardial apoptosis by postconditioning is associated with attenuation of oxidative stress-mediated nuclear factor-kappa B translocation and TNF alpha release. Shock, 29:761–768. 2008.
193.
KinH, ZhaoZQ, SunHY, WangNP, CorveraJS, HalkosME, KerendiF, GuytonRA, Vinten-JohansenJ. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res, 62:74–85. 2004.
194.
KinnallyKW, AntonssonB. A tale of two mitochondrial channels, MAC and PTP, in apoptosis. Apoptosis, 12:857–868. 2007.
195.
KitakazeM, AsakuraM, KimJ, ShintaniY, AsanumaH, HamasakiT, SeguchiO, MyoishiM, MinaminoT, OharaT, NagaiY, NantoS, WatanabeK, FukuzawaS, HirayamaA, NakamuraN, KimuraK, FujiiK, IshiharaM, SaitoY, TomoikeH, KitamuraS. J-WIND investigators. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet, 370:1483–1493. 2007.
196.
KlionskyDJ, AbeliovichH, AgostinisP, AgrawalDK, AlievG, AskewDSet al.Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy, 4:151–175. 2008.
197.
KokoszkaJE, WaymireKG, LevySE, SlighJE, CaiJ, JonesDP, MacGregorGR, WallaceDC. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature, 427:461–465. 2004.
198.
KorgeP, YangL, YangJH, WangY, QuZ, WeissJN. Protective role of transient pore openings in calcium handling by cardiac mitochondria. J Biol Chem, 286:348–357. 2011.
199.
KorichnevaI. Zinc dynamics in the myocardial redox signaling network. Antioxid Redox Signal, 8:1707–1721. 2006.
200.
KorzickDH, HolimanDA, BoluytMO, LaughlinMH, LakattaEG. Diminished alpha1-adrenergic-mediated contraction and translocation of PKC in senescent rat heart. Am J Physiol Heart Circ Physiol, 281:H581–H589. 2001.
201.
KorzickDH, LaughlinMH, BowlesDK. Alterations in PKC signaling underlie enhanced myogenic tone in exercise-trained porcine coronary resistance arteries. J Appl Physiol, 96:1425–1432. 2004.
202.
KristianT, BernardiP, SiesjoBK. Acidosis promotes the permeability transition in energized mitochondria: implications for reperfusion injury. J Neurotrauma, 18:1059–1074. 2001.
203.
KristiansenSB, LøfgrenB, StøttrupNB, KhatirD, Nielsen-KudskJE, NielsenTT, BøtkerHE, FlyvbjergA. Ischaemic preconditioning does not protect the heart in obese and lean animal models of type 2 diabetes. Diabetologia, 47:1716–1721. 2004.
204.
KukidomeD, NishikawaT, SonodaK, ImotoK, FujisawaK, YanoM, MotoshimaH, TaguchiT, MatsumuraT, ArakiE. Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. Diabetes, 55:120–127. 2006.
205.
KupaiK, CsonkaC, FeketeV, OdendaalL, van RooyenJ, Marais deW, CsontT, FerdinandyP. Cholesterol diet-induced hyperlipidemia impairs the cardioprotective effect of postconditioning: role of peroxynitrite. Am J Physiol Heart Circ Physiol, 297:H1729–H1735. 2009.
206.
KupattC, HinkelR, HorstkotteJ, DeißM, von BrühlM-L, BilzerM, BoekstegersP. Selective retroinfusion of GSH and cariporide attenuates myocardial ischemia-reperfusion injury in a preclinical pig model. Cardiovasc Res, 61:530–537. 2004.
207.
KutalaVK, KhanM, AngelosMG, KuppusamyP. Role of oxygen in postischemic myocardial injury. Antioxid Redox Signal, 9:1193–1206. 2007.
LambethJD. Nox enzymes and the biology of reactive oxygen. Nat Rev Immunol, 4:181–189. 2004.
212.
LecourS. Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: does it go beyond the RISK pathway?J Mol Cell Cardiol, 47:32–40. 2009.
213.
LemastersJJ. Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Res, 8:3–5. 2005.
214.
LemoineS, BuléonC, RouetR, IvascauC, BabatasiG, MassettiM, GérardJL, HanouzJL. Bradykinin and adenosine receptors mediate desflurane induced postconditioning in human myocardium: role of reactive oxygen species. BMC Anesthesiol, 10:12. 2010.
215.
LiXM, MaYT, YangYN, ZhangJF, ChenBD, LiuF, HuangY, HanW, GaoXM. Ischemic postconditioning protects hypertrophic myocardium by ERK1/2 signaling pathway: experiment with mice. Zhonghua Yi Xue Za Zhi, 89:846–850. 2009.
216.
LightPE. Cardiac KATP channels and ischemic preconditioning: current perspectives. Can J Cardiol, 15:1123–1130. 1999.
217.
LillyM, SandholmJ, CooperJJ, KoskinenPJ, KraftA. The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway. Oncogene, 18:4022–4031. 1999.
218.
LinJ, HandschinC, SpiegelmanBM. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab, 1:361–370. 2005.
219.
LinnaneAW, EastwoodH. Cellular redox regulation and prooxidant signaling systems: a new perspective on the free radical theory of aging. Ann NY Acad Sci, 1067:47–55. 2006.
220.
LiuB, TewariAK, ZhangL, Green-ChurchKB, ZweierJL, ChenYR, HeG. Proteomic analysis of protein tyrosine nitration after ischemia reperfusion injury: mitochondria as the major target. Biochim Biophys Acta, 1794:476–485. 2009.
221.
Lloyd-JonesD, AdamsRJ, BrownTM, CarnethonM, DaiS, De SimoneG, FergusonTB, FordE, FurieK, GillespieC, GoA, GreenlundK, HaaseN, HailpernS, HoPM, HowardV, KisselaB, KittnerS, LacklandD, LisabethL, MarelliA, McDermottMM, MeigsJ, MozaffarianD, MussolinoM, NicholG, RogerVL, RosamondW, SaccoR, SorlieP, StaffordR, ThomT, Wasserthiel-SmollerS, WongND, Wylie-RosettJ. Heart disease and stroke statistics—2010 update: a report from the american heart association. Circulation, 121:e46–e215. 2010.
222.
LoosB, GenadeS, EllisB, LochnerA, EngelbrechtAM. At the core of survival: autophagy delays the onset of both apoptotic and necrotic cell death in a model of ischemic cell injury. Exp Cell Res, 317:1437–1453. 2011.
223.
LuoW, LiB, ChenR, HuangR, LinG. Effect of ischemic postconditioning in adult valve replacement. Eur J Cardiothorac Surg, 33:203–208. 2008.
224.
MaH, GuoR, YuL, ZhangY, RenJ. Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial ischaemia/reperfusion injury: role of autophagy paradox and toxic aldehyde. Eur Heart J, 32:1025–1038. 2011.
225.
MaX, ZhangX, LiC, LuoM. Effect of postconditioning on coronary blood flow velocity and endothelial function and LV recovery after myocardial infarction. J Interv Cardiol, 19:367–375. 2006.
226.
ManintveldOC, Te Lintel HekkertM, van den BosEJ, SuurenbroekGM, DekkersDH, VerdouwPD, LamersJM, DunckerDJ. Cardiac effects of postconditioning depend critically on the duration of index ischemia. Am J Physiol Heart Circ Physiol, 292:H1551–H1560. 2007.
227.
McCullyJD, UematsuM, ParkerRA, LevitskyS. Adenosine-enhanced ischemic preconditioning provides enhanced cardioprotection in the aged heart. Ann Thorac Surg, 66:2037–2043. 1998.
McLeodCJ, AzizA, HoytRFJr., McCoyJPJr., SackMN. Uncoupling proteins 2 and 3 function in concert to augment tolerance to cardiac ischemia. J Biol Chem, 280:33470–33476. 2005.
230.
MewtonN, CroisilleP, GahideG, RioufolG, BonnefoyE, SanchezI, CungTT, SportouchC, AngoulvantD, FinetG, André-FouëtX, DerumeauxG, PiotC, VernhetH, RevelD, OvizeM. Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction. J Am Coll Cardiol, 55:1200–1205. 2010.
231.
MikiT, MiuraT, HottaH, TannoM, YanoT, SatoT, TerashimaY, TakadaA, IshikawaS, ShimamotoK. Endoplasmic reticulum stress in diabetic hearts abolishes erythropoietin-induced myocardial protection by impairment of phospho-glycogen synthase kinase-3 beta-mediated suppression of mitochondrial permeability transition. Diabetes, 58:2863–2872. 2009.
MurphyE, GlasgowW, FralixT, SteenbergenC. Role of lipoxygenase metabolites in ischemic preconditioning. Circ Res, 76:457–467. 1995.
238.
MurphyMP. How mitochondria produce reactive oxygen species. Biochem J, 417:1–13. 2009.
239.
MurryCE, JenningsRB, ReimerKA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation, 74:1124–1136. 1986.
240.
NadtochiySM, BakerPR, FreemanBA, BrookesPS. Mitochondrial nitroalkene formation and mild uncoupling in ischaemic preconditioning: implications for cardioprotection. Cardiovasc Res, 82:333–340. 2009.
241.
NadtochiySM, BurwellLS, IngrahamCA, SpencerCM, FriedmanE, PinkertCA, BrookesPS. In vivo cardioprotection by S-nitroso-2-mercaptopropionyl glycine. J Mol Cell Cardiol, 46:960–968. 2009.
242.
NaitoZ, TakashiE, XuG, IshiwataT, TedukaK, YokoyamaM, YamadaN, SugisakiY, AsanoG. Different influences of hyperglycemic duration on phosphorylated extracellular signal-regulated kinase 1/2 in rat heart. Exp Mol Pathol, 74:23–32. 2003.
243.
NakagawaT, ShimizuS, WatanabeT, YamaguchiO, OtsuK, YamagataH, InoharaH, KuboT, TsujimotoY. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature, 434:652–658. 2005.
244.
NaslundU, HaggmarkS, JohanssonG, PennertK, ReizS, MarklundSL. Effects of reperfusion and superoxide dismutase on myocardial infarct size in a closed chest pig model. Cardiovasc Res, 26:170–178. 1992.
245.
NikolaidisLA, MankadS, SokosGG, MiskeG, ShahA, ElahiD, ShannonRP. Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion. Circulation, 109:962–965. 2004.
NishiharaM, MiuraT, MikiT, TannoM, YanoT, NaitohK, OhoriK, HottaH, TerashimaY, ShimamotoK. Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection. J Mol Cell Cardiol, 43:564–557. 2007.
248.
NishinoY, WebbIG, DavidsonSM, AhmedAI, ClarkJE, JacquetS, ShahAM, MiuraT, YellonDM, AvkiranM, MarberMS. Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse. Circ Res, 103:307–314. 2008.
249.
ObameFN, Plin-MercierC, AssalyR, ZiniR, Dubois-RandeJL, BerdeauxA, MorinD. Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3β, SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1Hpyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore. J Pharmacol Exp Ther, 326:252–258. 2008.
250.
ObataK, YasueH, OkumuraK, MatsuyamaK, OgawaH, KuroseM, SaitoY, NakaoK, ImuraH, NobuyoshiM. Atrial natriuretic polypeptide is removed by the lungs and released into the left atrium as well as the right atrium in humans. J Am Coll Cardiol, 15:1537–1543. 1990.
251.
OhnumaY, MiuraT, MikiT, TannoM, KunoA, TsuchidaA, ShimamotoK. Opening of mitochondrial KATP channel occurs downstream of PKCɛ activation in the mechanism of preconditioning. Am J Physiol Heart Circ Physiol, 283:H440–H447. 2002.
OngSB, SubrayanS, LimSY, YellonDM, DavidsonSM, HausenloyDJ. Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation, 121:2012–2022. 2010.
256.
OrsiniF, MigliaccioE, MoroniM, ContursiC, RakerVA, PicciniD, Martin-PaduraI, PellicciaG, TrineiM, BonoM, PuriC, TacchettiC, FerriniM, MannucciR, NicolettiI, LanfranconeL, GiorgioM, PelicciPG. The life span determinant p66Shc localizes to mitochondria where it associates with mitochondrial heat shock protein 70 and regulates trans-membrane potential. J Biol Chem, 279:25689–25695. 2004.
257.
OsbakkenM, ItoK, ZhangD, PonomarenkoI, IvanicsT, JahngenEG, CohnM. Creatine and cyclocreatine effects on ischemic myocardium: 31P nuclear magnetic resonance evaluation of intact heart. Cardiology, 80:184–195. 1992.
258.
O'SheaJJ, GadinaM, SchreiberRD. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell, 109:S121–S131. 2002.
259.
OvizeM, BaxterGF, Di LisaF, FerdinandyP, Garcia-DoradoD, HausenloyDJ, HeuschG, Vinten-JohansenJ, YellonDM, SchulzR. Working Group of Cellular Biology of Heart of European Society of Cardiology. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res, 87:406–423. 2010.
260.
PagliaroP, MoroF, TullioF, PerrelliMG, PennaC. Cardioprotective pathways during reperfusion: focus on redox signaling and other modalities of cell signaling. Antioxid Redox Signal, 14:833–850. 2011.
PainT, YangX-M, CritzSD, YueY, NakanoA, LiuGS, HeuschG, CohenMV, DowneyJM. Opening of mitochondrial KATP channels triggers the preconditioned state by generating free radicals. Circ Res, 87:460–466. 2000.
263.
PaivaMA, Rutter-LocherZ, GonçalvesLM, ProvidênciaLA, DavidsonSM, YellonDM, MocanuMM. Enhancing AMPK activation during ischemia protects the diabetic heart against reperfusion injury. Am J Physiol Heart Circ Physiol, 300:H2123–H2134. 2011.
264.
PaolettiF, AldinucciD, MocaliA, CaparriniA. A sensitive spectrophotometric method for the determination of superoxide dismutase activity in tissue extracts. Analytical Biochemistry, 154:536–541. 1986.
265.
PatelHH, HsuAK, GrossGJ. COX-2 and iNOS in opioid-induced delayed cardioprotection in the intact rat. Life Sci, 75:129–140. 2004.
PennaC, AbbadessaG, MancardiD, TullioF, PiccioneF, SpaccamiglioA, RaccaS, PagliaroP. Synergistic effects against post-ischemic cardiac dysfunction by sub-chronic nandrolone pretreatment and postconditioning: role of beta2-adrenoceptor. J Physiol Pharmacol, 59:645–659. 2008.
268.
PennaC, CappelloS, MancardiD, RaimondoS, RastaldoR, GattulloD, LosanoG, PagliaroP. Post-conditioning reduces infarct size in the isolated rat heart: role of coronary flow and pressure and the nitric oxide/cGMP pathway. Basic Res Cardiol, 101:168–179. 2006.
269.
PennaC, MancardiD, RaimondoS, GeunaS, PagliaroP. The paradigm of postconditioning to protect the heart. J Cell Mol Med, 12:435–458. 2008.
270.
PennaC, MancardiD, RastaldoR, PagliaroP. Cardioprotection: a radical view Free radicals in pre and postconditioning. Biochim Biophys Acta-Bioenerg, 1787:781–793. 2009.
271.
PennaC, MancardiD, RastaldoR, LosanoG, PagliaroP. Intermittent activation of bradykinin B2 receptors and mitochondrial KATP channels trigger cardiac postconditioning through redox signaling. Cardiovasc Res, 75:168–177. 2007.
272.
PennaC, MancardiD, TullioF, PagliaroP. Intermittent adenosine at the beginning of reperfusion does not trigger cardioprotection. J Surg Res, 153:231–238. 2009.
273.
PennaC, MancardiD, TullioF, PagliaroP. Postconditioning and intermittent bradykinin induced cardioprotection require cyclooxygenase activation and prostacyclin release during reperfusion. Basic Res Cardiol, 103:368–377. 2008.
274.
PennaC, PerrelliMG, RaimondoS, TullioF, MerlinoA, MoroF, GeunaS, MancardiD, PagliaroP. Postconditioning induces an anti-apoptotic effect and preserves mitochondrial integrity in isolated rat hearts. Biochim Biophys Acta-Bioenerg, 1787:794–801. 2009.
275.
PennaC, PerrelliMG, TullioF, MoroF, ParisellaML, MerlinoA, PagliaroP. Post-ischemic early acidosis in cardiac postconditioning modifies the activity of antioxidant enzymes, reduces nitration, and favors protein S-nitrosylation. Pflugers Arch, 462:219–233. 2011.
276.
PennaC, RastaldoR, MancardiD, RaimondoS, CappelloS, GattulloD, LosanoG, PagliaroP. Post-conditioning induced cardioprotection requires signaling through a redox-sensitive mechanism, mitochondrial ATP-sensitive K+ channel and protein kinase C activation. Basic Res Cardiol, 101:180–189. 2006.
277.
PennaC, TullioF, MerlinoA, MoroF, RaimondoS, RastaldoR, PerrelliMG, MancardiD, PagliaroP. Postconditioning cardioprotection against infarct size and post-ischemic systolic dysfunction is influenced by gender. Basic Res Cardiol, 104:390–402. 2009.
278.
PennaC, TullioF, MoroF, FolinoA, MerlinoA, PagliaroP. Effects of a protocol of ischemic postconditioning and/or captopril in hearts of normotensive and hypertensive rats. Basic Res Cardiol, 105:181–192. 2010.
279.
PennaC, TullioF, PerrelliMG, MoroF, AbbadessaG, PiccioneF, CarrieroV, RaccaS, PagliaroP. Ischemia/reperfusion injury is increased and cardioprotection by a postconditioning protocol is lost as cardiac hypertrophy develops in nandrolone treated rats. Basic Res Cardiol, 106:409–420. 2011.
280.
PerseghinG, PetersenK, ShulmanGI. Cellular mechanism of insulin resistance: potential links with inflammation. Int J Obes Relat Metab Disord, 27:S6–S11. 2003.
281.
PetersonLR, HerreroP, SchechtmanKB, RacetteSB, WaggonerAD, Kisrieva-WareZ, DenceC, KleinS, MarsalaJ, MeyerT, GroplerRJ. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation, 109:2191–2196. 2004.
282.
PetronilliV, MiottoG, CantonM, BriniM, ColonnaR, BernardiP, Di LisaF. Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Biophys J, 76:725–734. 1999.
283.
PetronilliV, PenzoD, ScorranoL, BernardiP, Di LisaF. The mitochondrial permeability transition, release of cytochrome c and cell death. Correlation with the duration of pore openings in situ. J Biol Chem, 276:12030–12034. 2001.
284.
PiotC, CroisilleP, StaatP, ThibaultH, RioufolG, MewtonN, ElbelghitiR, CungTT, BonnefoyE, AngoulvantD, MaciaC, RaczkaF, SportouchC, GahideG, FinetG, André-FouëtX, RevelD, KirkorianG, MonassierJP, DerumeauxG, OvizeM. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med, 359:473–481. 2008.
285.
PiperHM, AbdallahY, SchäferC. The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc Res, 61:365–371. 2004.
286.
PiperHM, Garcia-DoradoD, OvizeM. A fresh look at reperfusion injury. Cardiovasc Res, 38:291–300. 1998.
287.
PiperHM, KasseckertS, AbdallahY. The sarcoplasmic reticulum as the primary target of reperfusion protection. Cardiovasc Res, 70:170–173. 2006.
288.
PrimeTA, BlaikieFH, EvansC, NadtochiySM, JamesAM, DahmCC, VitturiDA, PatelRP, HileyCR, AbakumovaI, RequejoR, ChouchaniET, HurdTR, GarveyJF, TaylorCT, BrookesPS, SmithRA, MurphyMP. A mitochondria-targeted S-nitrosothiol modulates respiration, nitrosates thiols, and protects against ischemia-reperfusion injury. Proc Natl Acad Sci U S A, 106:10764–10769. 2009.
289.
PrzyklenkK, KlonerRA. “Reperfusion injury” by oxygen-derived free radicals? Effect of superoxide dismutase plus catalase, given at the time of reperfusion, on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow. Circ Res, 64:86–96. 1989.
290.
PrzyklenkK, DongY, UndyalaVV, WhittakerP. Autophagy as a therapeutic target for ischemia-reperfusion injury? Concepts, controversies and challenges. Cardiovasc Res, 2012[Epub ahead of print]DOI:10.1093/cvr/cvr358
291.
PrzyklenkK, LiG, SimkhovichBZ, KlonerRA. Mechanisms of myocardial ischemic preconditioning are age related: PKC-epsilon does not play a requisite role in old rabbits. J Appl Physiol, 95:2563–2569. 2003.
292.
PrzyklenkK, MaynardM, DarlingCE, WhittakerP. Aging mouse hearts are refractory to infarct size reduction with post-conditioning. J Am Coll Cardiol, 51:1393–1398. 2008.
293.
PrzyklenkK, MaynardM, GreinerDL, WhittakerP. Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes. Antioxid Redox Signal, 14:781–790. 2011.
QueliconiBB, WojtovichAP, NadtochiySM, KowaltowskiAJ, BrookesPS. Redox regulation of the mitochondrial KATP channel in cardioprotection. Biochim Biophys Acta, 1813:1309–1315. 2011.
296.
QuinlanCL, CostaAD, CostaCL, PierreSV, Dos SantosP, GarlidKD. Conditioning the heart induces formation of signalosomes that interact with mitochondria to open mitoKATP channels. Am J Physiol Heart Circ Physiol, 295:H953–H961. 2008.
297.
RajeshKG, SasaguriS, ZhitianZ, SuzukiR, AsakaiR, MaedaH. Second window of ischemic preconditioning regulates mitochondrial permeability transition pore by enhancing Bcl-2 expression. Cardiovasc Res, 59:297–307. 2003.
298.
RaphaelJ, GozalY, NavotN, ZuoZ. Hyperglycemia inhibits anesthetic-induced postconditioning in the rabbit heart via modulation of phosphatidylinositol-3-kinase/Akt and endothelial nitric oxide synthase signaling. J Cardiovasc Pharmacol, 55:348–357. 2010.
299.
RasolaA, SciacovelliM, ChiaraF, PanticB, BrusilowWS, BernardiP. Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition. Proc Natl Acad Sci U S A, 107:726–731. 2010.
300.
RobinE, GuzyRD, LoorG, IwaseH, WaypaGB, MarksJD, HoekTL, SchumackerPT. Oxidant Stress during simulated Ischemia primes cardiomyocytes for cell death during reperfusion. J Biol Chem, 282:19133–19143. 2007.
301.
Rodriguez-SinovasA, BoenglerK, CabestreroA, GresP, MorenteM, Ruiz-MeanaM, KonietzkaI, MiróE, TotzeckA, HeuschG, SchulzR, Garcia-DoradoD. Translocation of connexin 43 to the inner mitochondrial membrane of cardiomyocytes through the heat shock protein 90-dependent TOM pathway and its importance for cardioprotection. Circ Res, 99:93–101. 2006.
302.
RoeMT, MessengerJC, WeintraubWS, CannonCP, FonarowGC, DaiD, ChenAY, KleinLW, MasoudiFA, McKayC, HewittK, BrindisRG, PetersonED, RumsfeldJS. Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol, 56:254–263. 2010.
303.
RossAM, GibbonsRJ, StoneGW, KlonerRA, AlexanderRW. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II)J Am Coll Cardiol, 45:1775–1780. 2005.
304.
RottlaenderD, BoenglerK, WolnyM, MichelsG, Endres-BeckerJ, MotlochLJ, SchwaigerA, BuechertA, SchulzR, HeuschG, HoppeUC. Connexin 43 acts as a cytoprotective mediator of signal transduction by stimulating mitochondrial KATP channels in mouse cardiomyocytes. J Clin Invest, 120:1441–1453. 2010.
305.
Ruiz-MeanaM, AbellánA, Miró-CasasE, Garcia-DoradoD. Opening of mitochondrial permeability transition pore induces hypercontracture in Ca2+ overloaded cardiac myocytes. Basic Res Cardiol, 102:542–552. 2007.
306.
SackMN. Mitochondrial depolarization and the role of uncoupling proteins in ischemia tolerance. Cardiovasc Res, 72:210–219. 2006.
SaotomeM, KatohH, YaguchiY, TanakaT, UrushidaT, SatohH, HayashiH. Transient opening of mitochondrial permeability transition pore by reactive oxygen species protects myocardium from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol, 296:H1125–H1132. 2009.
309.
SarkelaTM, BerthiaumeJ, ElferingS, GybinaAA, GiuliviC. The modulation of oxygen radical production by nitric oxide in mitochondria. J Biol Chem, 276:6945–6949. 2001.
310.
SasakiN, SatoT, OhlerA, O'RourkeB, MarbanE. Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. Circulation, 101:439–445. 2000.
311.
SatoH, BolliR, RokoshGD, BiQ, DaiS, ShirkG, TangXL. The cardioprotection of the late phase of ischemic preconditioning is enhanced by postconditioning via a COX-2-mediated mechanism in conscious rats. Am J Physiol Heart Circ Physiol, 293:H2557–H2564. 2007.
312.
ScarpullaRC. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev, 88:611–638. 2008.
Scheuermann-FreestoneM, MadsenPL, MannersD, BlamireAM, BuckinghamRE, StylesP, RaddaGK, NeubauerS, ClarkeK. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation, 107:3040–3046. 2003.
315.
SchneiderSH, AmorosaLF, KhachadurianAK, RudermanNB. Studies on the mechanism of improved glucose control during regular exercise in type 2 (non-insulin dependent) diabetes. Diabetologia, 26:355–360. 1984.
316.
SchrauwenP, HesselinkMKC. Oxidative capacity, lipotoxicity and mitochondrial damage in type 2 diabetes. Diabetes, 53:1412–1417. 2004.
317.
SchrauwenP. Skeletal muscle uncoupling protein 3 (UCP3): mitochondrial uncoupling protein in search of a function. Curr Opin Clin Nutr Metab Care, 5:265–270. 2002.
318.
SchwankeU, KonietzkaI, DuschinA, LiX, SchulzR, HeuschG. No ischemic preconditioning in heterozygous connexin43-deficient mice. Am J Physiol Heart Circ Physiol, 283:H1740–H1742. 2002.
319.
ScorranoL, PenzoD, PetronilliV, PaganoF, BernardiP. Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor-alpha apoptotic signaling. J Biol Chem, 276:12035–12040. 2001.
320.
ShenX, ZhengS, MetreveliN S, EpsteinPN. Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy. Diabetes, 55:798–805. 2006.
321.
ShenX, ZhengSR, ThongboonkerdV, XuM, PierceWM, KleinJB, EpsteinPN. Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes. Am J Physiol Endocrinol Metab, 287:E896–E905. 2004.
322.
ShinSM, ChoIJ, KimSG. Resveratrol protects mitochondria against oxidative stress through AMP-activated protein kinase-mediated glycogen synthase kinase-3beta inhibition downstream of poly(ADP-ribose)polymerase-LKB1 pathway. Mol Pharmacol, 76:884–895. 2009.
323.
ShinmuraK, NagaiM, TamakiK, BolliR. Gender and aging do not impair opioid-induced late preconditioning in rats. Basic Res Cardiol, 99:46–55. 2004.
324.
ShivaS, SackMN, GreerJJ, DuranskiM, RingwoodLA, BurwellL, WangX, MacArthurPH, ShojaA, RaghavachariN, CalvertJW, BrookesPS, LeferDJ, GladwinMT. Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J Exp Med, 204:2089–2102. 2007.
325.
ShulgaN, PastorinoJG. Acyl coenzyme A-binding protein augments bid-induced mitochondrial damage and cell death by activating mu-calpain. J Biol Chem, 281:30824–30833. 2006.
326.
SivaramanV, MudalagiriNR, Di SalvoC, KolvekarS, HaywardM, YapJ, KeoghB, HausenloyDJ, YellonDM. Postconditioning protects human atrial muscle through the activation of the RISK pathway. Basic Res Cardiol, 102:453–459. 2007.
327.
SkyschallyA, HeuschG. Reduction of myocardial infarct size by dronedarone in pigs—a pleiotropic action?Cardiovasc Drugs Ther, 25:197–201. 2011.
328.
SkyschallyA, van CasterP, BoenglerK, GresP, MusiolikJ, SchilawaD, SchulzR, HeuschG. Ischemic postconditioning in pigs: no causal role for RISK activation. Circ Res, 104:15–18. 2009.
329.
SkyschallyA, van CasterP, IliodromitisEK, SchulzR, KremastinosDT, HeuschG. Ischemic postconditioning: experimental models and protocol algorithms. Basic Res Cardiol, 104:469–483. 2009.
SorenssonP, SalehN, BouvierF, BohmF, SettergrenM, CaidahlK, TornvallP, ArhedenH, RydenL, PernowJ. Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction. Heart, 96:1710–1715. 2010.
333.
StaatP, RioufolG, PiotC, CottinY, CungTT, L'HuillierI, AupetitJF, BonnefoyE, FinetG, Andre-FouetX, OvizeM. Postconditioning the human heart. Circulation, 112:2143–2148. 2005.
334.
StoweDF, CamaraAK. Mitochondrial reactive oxygen species production in excitable cells: modulators of mitochondrial and cell function. Antioxid Redox Signal, 11:1373–1414. 2009.
335.
St-PierreJ, DroriS, UldryM, SilvaggiJM, RheeJ, JagerS, HandschinC, ZhengK, LinJ, YangW, SimonDK, BachooR, SpiegelmanBM. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell, 127:397–408. 2006.
336.
StumpnerJ, RedelA, KellermannA, LotzCA, BlomeyerCA, SmulTM, KehlF, RoewerN, LangeM. Differential role of Pim-1 kinase in anesthetic-induced and ischemic preconditioning against myocardial infarction. Anesthesiology, 111:1257–1264. 2009.
337.
SuleimanM-S, HalestrapAP, GriffithsEJ. Mitochondria: a target for myocardial protection. Pharmacol Ther, 89:29–46. 2001.
338.
SunHY, WangNP, HalkosM, KerendiF, KinH, GuytonRA, Vinten-JohansenJ, ZhaoZQ. Postconditioning attenuates cardiomyocyte apoptosis via inhibition of JNK and p38 mitogen-activated protein kinase signaling pathways. Apoptosis, 11:1583–1593. 2006.
339.
SunHY, WangNP, KerendiF, HalkosM, KinH, GuytonRA, Vinten-JohansenJ, ZhaoZQ. Hypoxic postconditioning reduces cardiomyocyte loss by inhibiting ROS generation and intracellular Ca2+ overload. Am J Physiol Heart Circ Physiol, 288:H1900–H1908. 2005.
340.
SunJ, MorganM, ShenRF, SteenbergenC, MurphyE. Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport. Circ Res, 101:1155–1163. 2007.
341.
SunJ, SteenbergenC, MurphyE. S-nitrosylation: NO-related redox signaling to protect against oxidative stress. Antioxid Redox Signal, 8:1693–1705. 2006.
342.
SunJZ, TangXL, KnowltonAA, ParkSW, QiuY, BolliR. Late preconditioning against myocardial stunning. An endogenous protective mechanism that confers resistance to postischemic dysfunction 24 h after brief ischemia in conscious pigs. J Clin Invest, 95:388–403. 1995.
343.
SzczepanekK, ChenQ, DereckaM, SalloumFN, ZhangQ, SzelagM, CichyJ, KukrejaRC, DulakJ, LesnefskyEJ, LarnerAC. Mitochondrial-targeted signal transducer and activator of transcription (STAT3) protects against ischemiainduced changes in the electron transport chain and the generation of reactive oxygen species. J Biol Chem, 286:29610–29620. 2011.
344.
SzczepanekK, ChenQ, LarnerAC, LesnefskyEJ. Cytoprotection by the modulation of mitochondrial electron transport chain: the emerging role of mitochondrial STAT3. Mitochondrion, 12:180–189. 2012.
345.
SzekeresL. Drug-induced delayed cardiac protection against the effects of myocardial ischemia. Pharmacol Ther, 108:269–280. 2005.
346.
TaimorG. Mitochondria as common endpoints in early and late preconditioning. Cardiovasc Res, 59:266–267. 2003.
347.
TakagiH, MatsuiY, SadoshimaJ. The role of autophagy in mediating cell survival and death during ischemia and reperfusion in the heart. Antioxid Redox Signal, 9:1373–1381. 2007.
348.
TakanoH, TangXL, KodaniE, BolliR. Late preconditioning enhances recovery of myocardial function after infarction in conscious rabbits. Am J Physiol, 279:H2372–H2381. 2000.
349.
TakashiE, WangY, AshrafM. Activation of mitochondrial K(ATP) channel elicits late preconditioning against myocardial infarction via protein kinase C signaling pathway. Circ Res, 85:1146–1153. 1999.
350.
TanakaK, KehlF, GuW, KrolikowskiJG, PagelPS, WarltierDC, KerstenJR. Isoflurane-induced preconditioning is attenuated by diabetes. Am J Physiol Heart Circ Physiol, 282:H2018–H2023. 2002.
351.
TermanA, BrunkUT. Autophagy in cardiac myocyte homeostasis, aging, and pathology. Cardiovasc Res, 68:355–365. 2005.
352.
TerrellAM, CrisostomoPR, WairiukoGM, WangM, MorrellED, MeldrumDR. JAK/STAT/SOCS signaling circuits and asociated cytokine-mediated inflammation and hypertrophy in the heart. Shock, 26:226–234. 2006.
ThomasDD, RidnourLA, IsenbergJS, Flores-SantanaW, SwitzerCH, DonzelliS, HussainP, VecoliC, PaolocciN, AmbsS, ColtonCA, HarrisCC, RobertsDD, WinkDA. The chemical biology of nitric oxide: implications in cellular signaling. Free Radic Biol Med, 45:18–31. 2008.
355.
TianY, ZhangW, XiaD, ModiP, LiangD, WeiM. Postconditioning inhibits myocardial apoptosis during prolonged reperfusion via a JAK2-STAT3-Bcl-2 pathway. J Biomed Sci, 18:53. 2011
356.
TongH, ImahashiK, SteenbergenC, MurphyE. Phosphorylation of glycogen synthase kinase-3β during preconditioning through a phosphatidylinositol-3-kinase-dependent pathway is cardioprotective. Circ Res, 90:374–376. 2002.
357.
TotzeckA, BoenglerK, Van deSA, KonietzkaI, GresP, Garcia-DoradoD, HeuschG, SchulzR. No impact of protein phosphatases on connexin 43 phosphorylation in ischemic preconditioning. Am J Physiol Heart Circ Physiol, 295:H2106–H2112. 2008.
358.
TrittoI, AmbrosioG. Role of oxidants in the signaling pathway of preconditioning. Antioxid Redox Signal, 3:3–10. 2001.
359.
TsangA, HausenloyDJ, MocanuMM, CarrRD, YellonDM. Preconditioning the diabetic heart: the importance of Akt phosphorylation. Diabetes, 54:2360–2364. 2005.
360.
TsutsumiY, MatsubaraH, MasakiH, KuriharaH, MurasawaS, TakaiS, MiyazakiM, NozawaY, OzonoR, NakagawaK, MiwaT, KawadaN, MoriY, ShibasakiY, TanakaY, FujiyamaS, KoyamaY, FujiyamaA, TakahashiH, IwasakaT. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest, 104:925–935. 1999.
361.
TsutsumiYM, YokoyamaT, HorikawaY, RothDM, PatelHH. Reactive oxygen species trigger ischemic and pharmacological postconditioning: in vivo and in vitro characterization. Life Sci, 81:1223–1227. 2007.
362.
TurkoIV, MuradF. Protein nitration in cardiovascular diseases. Pharmacol Rev, 54:619–634. 2002.
363.
Vanden HoekTL, BeckerLB, ShaoZ-H, LiC-Q, SchumackerPT. Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion. Circ Res, 86:541–548. 2000.
364.
Vanden HoekTL, LiC, ShaoZ, SchumackerPT, BeckerLB. Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J Mol Cell Cardiol, 29:2571–2583. 1997.
365.
Vanden HoekTL, ShaoZ, LiC, SchumackerPT, BeckerLB. Mitochondrial electron transport can become a significant source of oxidative injury in cardiomyocytes. J Mol Cell Cardiol, 29:2441–2450. 1997.
366.
VeghA, KomoriS, SzekeresL, ParrattJR. Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats. Cardiovasc Res, 26:487–495. 1992.
367.
Vinten-JohansenJ, BuckbergGD, OkamotoF, RosenkranzER, BugyiH, LeafJ. Superiority of surgical versus medical reperfusion after regional ischemia. J Thorac Cardiovasc Surg, 92:525–534. 1986.
368.
Vinten-JohansenJ, GranfeldtA, MykytenkoJ, UndyalaVV, DongY, PrzyklenkK. The multi-dimensional physiological responses to postconditioning. Antioxid Redox Signal, 14:791–810. 2011.
369.
Vinten-JohansenJ, ZhaoZQ, ZattaAJ, KinH, HalkosME, KerendiF. Postconditioning. A new link in nature's armor against myocardial ischemia reperfusion injury. Basic Res Cardiol, 295:295–310. 2005.
370.
ViolletB, AndreelliF, JørgensenSB, PerrinC, GeloenA, FlamezD, MuJ, WagnerC, KloetingI, StrasserRH, WeinbrennerC. Cardioprotection by postconditioning is lost in WOKW rats with metabolic syndrome: role of glycogen synthase kinase 3beta. J Cardiovasc Pharmacol, 52:430–437. 2008.
371.
WagnerC, TillackD, SimonisG, StrasserRH, WeinbrennerC. Ischemic postconditioning reduces infarct size of the in vivo rat heart: role of PI3-K, mTOR, GSK-3beta, and apoptosis. Mol Cell Biochem, 339:135–147. 2010.
WilliamsSD, GottliebRA. Inhibition of mitochondrial calcium-independent phospholipase A2 (iPLA2) attenuates mitochondrial phospholipid loss and is cardioprotective. Biochem J, 362:23–32. 2002.
YellonDM, HausenloyDJ. Realizing the clinical potential of ischemic preconditioning and postconditioning. Nat Clin Pract Cardiovasc. Med, 2:568–575. 2005.
385.
YinZ, GaoH, WangH, LiL, DiC, LuanR, TaoL. Ischaemic post-conditioning protects both adult and aged Sprague-Dawley rat heart from ischaemia-reperfusion injury through the phosphatidylinositol 3-kinase-AKT and glycogen synthase kinase-3beta pathways. Clin Exp Pharmacol Physiol, 36:756–763. 2009.
386.
YouleRJ, StrasserA. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol, 9:47–59. 2008.
387.
YueY, QinQ, CohenMV, DowneyJM, CritzSD. The relative order of mK(ATP) channels, free radicals and p38 MAPK in preconditioning's protective pathway in rat heart. Cardiovasc Res, 55:681–689. 2002.
388.
ZattaAJ, KinH, LeeG, WangN, JiangR, LustR, ReevesJG, MykytenkoJ, GuytonRA, ZhaoZQ, Vinten-JohansenJ. Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling. Cardiovasc Res, 70:315–324. 2006.
ZhangY, XiaZ, La CourKH, RenJ. Activation of Akt rescues endoplasmic reticulum stress-impaired murine cardiac contractile function via glycogen synthase kinase-3β-mediated suppression of mitochondrial permeation pore opening. Antioxid Redox Signal, 15:2407–2424. 2011.
391.
ZhangYY, XuAM, NomenM, WalshM, KeaneyJFJr., TurkoIV, MuradF, LoscalzoJ. Nitrosation of tryptophan residue(s) in serum albumin and model dipeptides. Biochemical characterization and bioactivity. J Biol Chem, 271:14271–14279. 1996.
ZmijewskiJW, BanerjeeS, BaeH, FriggeriA, LazarowskiER, AbrahamE. Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase. J Biol Chem, 285:33154–33164. 2010.
396.
ZorovDB, FilburnCR, KlotzLO, ZweierJL, SollottSJ. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med, 192:1001–1014. 2000.
397.
ZorovDB, JuhaszovaM, SollottSJ. Mitochondrial ROS-induced ROS release: an update and review. Biochim Biophys Acta, 1757:509–517. 2006.
398.
ZorovDB, JuhaszovaM, YanivY, NussHB, WangS, SollottSJ. Regulation and pharmacology of the mitochondrial permeability transition pore. Cardiovasc Res, 83:213–225. 2009.
399.
ZouM, MartinC, UllrichV. Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite. Biol Chem, 378:707–713. 1997.
400.
ZouMH, KirkpatrickSS, DavisBJ, NelsonJS, WilesWG4th, SchlattnerU, NeumannD, BrownleeM, FreemanMB, GoldmanMH. Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species. J Biol Chem, 279:43940–43951. 2004.
401.
ZweierJL, WangP, KuppusamyP. Direct measurement of nitric oxide generation in the ischemic heart using electron paramagnetic resonance spectroscopy. J Biol Chem, 270:304–307. 1995.
